Biden-Harris Administration Expands At-Home COVID-19 Options
This week, the Biden-Harris Administration announced it would invest $1 billion to support the development and availability of at-home rapid tests for COVID-19. The Administration announced the infusion of funding will quadruple the number of at-home tests available for Americans by December.
The increase in tests is anticipated to help improve access to at-home testing for individuals who need tests for school and work or after a close contact with an infected person. The U.S. Food and Drug Administration (FDA) approved an emergency use authorization (EUA) for a new at-home rapid test from ACON Laboratories on Monday, and the Biden-Harris Administration has secured commitments from two other manufacturers to expand production of their tests.
In addition to the at-home testing options, the Biden-Harris Administration announced an expansion of the federal government’s free local pharmacy COVID-19 testing program. The Administration will be doubling the number of pharmacies to 20,000 to ensure free COVID-19 testing in communities throughout the country.
Additional information is available here.